Using CRISPR to decipher whether gene variants lead to cancer

Researchers at ETH Zurich have combined two gene editing methods. This enables them to quickly investigate the significance of many genetic mutations involved in the development and treatment of cancer.

This image shows the DNA bases
State-of-the-art CRISPR-Cas methods can be used to precisely exchange individual DNA bases. (Image: Lightfield Studios / Shutterstock)
JavaScript has been disabled in your browser